P
Philip C. Calder
Researcher at University of Southampton
Publications - 808
Citations - 70822
Philip C. Calder is an academic researcher from University of Southampton. The author has contributed to research in topics: Polyunsaturated fatty acid & Eicosapentaenoic acid. The author has an hindex of 125, co-authored 747 publications receiving 59110 citations. Previous affiliations of Philip C. Calder include Southampton General Hospital & Radboud University Nijmegen Medical Centre.
Papers
More filters
Journal ArticleDOI
Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic
Colin Hill,Francisco Guarner,Gregor Reid,Glenn R. Gibson,Daniel Merenstein,Bruno Pot,Lorenzo Morelli,Roberto Berni Canani,Harry J. Flint,Seppo Salminen,Philip C. Calder,Mary Ellen Sanders +11 more
TL;DR: An expert panel was convened in October 2013 by the International Scientific Association for Probiotics and Prebiotics (ISAPP) to discuss the field of probiotics and the appropriate use and scope of the term probiotic.
Journal ArticleDOI
n−3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases
TL;DR: At sufficiently high intakes, long-chain n-3 polyunsaturated fatty acids (PUFAs), as found in oily fish and fish oils, decrease the production of inflammatory eicosanoids, cytokines, and reactive oxygen species and the expression of adhesion molecules, and are potentially potent antiinflammatory agents.
Journal ArticleDOI
ESPEN Guidelines on Parenteral Nutrition: intensive care.
Pierre Singer,Mette M. Berger,Greet Van den Berghe,Gianni Biolo,Philip C. Calder,Alastair Forbes,Richard D. Griffiths,Georg Kreyman,Xavier Leverve,Claude Pichard +9 more
TL;DR: The authors will present not only the evidence available regarding the indications for PN, its implementation, the energy required, its possible complementary use with enteral nutrition, but also the relative importance of the macro- and micronutrients in the formula proposed for the critically ill patient.
Journal ArticleDOI
ESPEN guideline on clinical nutrition in the intensive care unit
Pierre Singer,Annika Reintam Blaser,Mette M. Berger,Waleed Alhazzani,Philip C. Calder,Michael P Casaer,Michael Hiesmayr,Konstantin Mayer,J.C. Montejo,Claude Pichard,Jean-Charles Preiser,Arthur R. H. van Zanten,Simon Oczkowski,Wojciech Szczeklik,Stephan C. Bischoff +14 more
TL;DR: Particular conditions frequently observed in intensive care such as patients with dysphagia, frail patients, multiple trauma patients, abdominal surgery, sepsis, and obesity are discussed to guide the practitioner toward the best evidence based therapy.
Journal ArticleDOI
Marine omega-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance
TL;DR: Mechanisms underlying the anti-inflammatory actions of marine n-3 fatty acids include altered cell membrane phospholipid fatty acid composition, disruption of lipid rafts, and inhibition of activation of the pro-inflammatory transcription factor nuclear factor kappa B so reducing expression of inflammatory genes.